Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination. Birabaharan M, Kaelber DC, Orme CM, Paravar T, et al. Br J Dermatol 2022;187:271-273.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Birabaharan M, Kaelber DC, Orme CM, Paravar T, et al. Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination. Br J Dermatol 2022;187:271-273.
PMID: 35279833